Cargando…
Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications—Focus on Prostate and Breast Cancer
Prostate and breast cancer are the second most and most commonly diagnosed cancer in men and women worldwide, respectively. The American Cancer Society estimates that during 2016 in the USA around 430,000 individuals were diagnosed with one of these two types of cancers, and approximately 15% of the...
Autor principal: | Elgqvist, Jörgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455010/ https://www.ncbi.nlm.nih.gov/pubmed/28531102 http://dx.doi.org/10.3390/ijms18051102 |
Ejemplares similares
-
Targeting Prostate Cancer Stem Cells with Alpha-Particle Therapy
por: Ceder, Jens, et al.
Publicado: (2017) -
Theranostics Applications of Nanoparticles in Cancer Immunotherapy
por: Liu, Yihai, et al.
Publicado: (2018) -
Persistent luminescence nanoparticles for cancer theranostics application
por: Liu, Nian, et al.
Publicado: (2021) -
Preclinical efficacy of hK2 targeted [(177)Lu]hu11B6 for prostate cancer theranostics
por: Timmermand, Oskar Vilhelmsson, et al.
Publicado: (2019) -
Theranostic applications of nanoparticles in neurodegenerative disorders
por: Ramanathan, Sahana, et al.
Publicado: (2018)